Allergy and Immunology
-
Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2
This article has 13 authors:Reviewed by ScreenIT
-
Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
This article has 8 authors:Reviewed by ScreenIT
-
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
This article has 25 authors:Reviewed by ScreenIT
-
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose
This article has 25 authors:Reviewed by ScreenIT
-
Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through the Analysis of Spike Protein-Specific Core Unique Peptides
This article has 4 authors:Reviewed by ScreenIT
-
A magnetic bead immunoassay to detect high affinity human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli
This article has 8 authors:Reviewed by ScreenIT
-
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
This article has 30 authors:Reviewed by ScreenIT
-
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
This article has 14 authors:Reviewed by ScreenIT
-
Assessing anti‐SARS‐CoV‐2 cellular immunity in 571 vaccines by using an IFN‐γ release assay
This article has 21 authors:Reviewed by ScreenIT
-
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
This article has 25 authors:Reviewed by ScreenIT